Pediatric Oncology Medical Director - Care and Innovation

Nicklaus Children's; Miami (FL); On-site; USD 260,000 - 380,000; Full time

Job summary

Miami Children’s Hospital is seeking a Medical Director for the Helen & Jacob Shaham Cancer & Blood Disorders Institute. The leader will guide strategic and clinical directions, oversee operations, and drive research and academic growth for pediatric cancer and blood disorders.

The role requires extensive experience in pediatric hematology/oncology, strong leadership, and a track record of collaboration with philanthropy, academia, and clinical partners.

Qualifications

• MD or DO from an accredited medical school.
• Florida medical license in good standing.
• Board certification in Pediatric Hematology/Oncology.
• 8–10 years of leadership in pediatric hematology/oncology.
• Experience engaging donors and academic partners.

Responsibilities

• Provide strategic and clinical leadership for the pediatric hematology/oncology program.
• Oversee clinical operations, research direction, academic growth, and program development.
• Lead quality improvement, patient safety, and outcomes initiatives.
• Oversee research portfolio and grant-funded initiatives.
• Represent the Institute publicly and engage with donors and partners.
• Coordinate with hospital administration on growth plans and budget.

Skills

Leadership

Academic medicine

Strategic planning

Communication

Education

M.D. or D.O.

Florida medical license (in good standing)

Board certification: Pediatric Hematology/Oncology

8–10 years of clinical leadership experience

Job description

Miami Children’s Hospital is seeking a Medical Director for the Helen & Jacob Shaham Cancer & Blood Disorders Institute. The leader will guide strategic and clinical directions, oversee operations, and drive research and academic growth for pediatric cancer and blood disorders.

The role requires extensive experience in pediatric hematology/oncology, strong leadership, and a track record of collaboration with philanthropy, academia, and clinical partners.